TOTAL ANTIBODY DETECTION ELISA

SARS-COV-2 CLINICAL DIAGNOSTIC KITS – QUICK AND EFFECTIVE

Diagnosis

While molecular diagnostic techniques are a direct indicator of disease, serological techniques are an indirect diagnostic assay, which determines whether a person has overcome the disease and is therefore immunized. Thus, it is a complementary technique to PCR, especially in those cases where PCR gives a negative result.

The GSD INgezim COVID assays use the SARS-CoV-2 nucleoprotein (N protein) as the antigen for the detection of antibodies to SARS-CoV-2. The N protein is one of the most abundant early-onset proteins of the virus, as well as being highly immunogenic and therefore a good candidate antigen for the diagnosis of COVID19.

Status Determination

The presence of specific antibodies to SARS-CoV-2 in patient samples indirectly proves that the individual has suffered from the infection.

TOTAL ANTIBODY DETECTION ELISA IMMUNOASSAYS

GSD INGEZIM COVID 19 DR

ART. NO.

GSD.R.50.CoV.K0

PRODUCT

GSD INgezym COVID 19 DR

NUMBER OF TESTS

96

DESCRIPTION

Double recognition ELISA for the determination of total antibodies in serum samples.

***GSD Update: Gold Standard Diagnostics SARS-COV-2 Total Antibody Detection ELISA has been submitted to the FDA for EUA.***